Erectile-dysfunction therapies

descriptionPublicationkeyboard_double_arrow_right Article 01 Sep 2002 English Publisher:Springer Science and Business Media LLCJournal:Nature Reviews Drug Discovery, volume 1, pages 663-664 (issn: 1474-1776, eissn: 1474-1784,

Copyright policy )

Authors: Ronald C, Renaud; Hayley, Xuereb;

doi: 10.1038/nrd898

pmid: 12216576

Erectile-dysfunction therapies

- Summary
- Subjects
- Metrics

No summary information available

Keywords

Adult, Male, Phosphodiesterase Inhibitors, Middle Aged, Piperazines, Sildenafil Citrate, United States, Psychotherapy, Erectile Dysfunction, Purines, Humans, Sulfones, Aged

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	17
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average